NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 248 filers reported holding NEKTAR THERAPEUTICS in Q4 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $118,479 | +41618.0% | 168,558 | +34.1% | 0.00% | -75.0% |
| Q4 2022 | $284 | -99.9% | 125,741 | -6.3% | 0.00% | -42.9% |
| Q3 2022 | $429,000 | -15.7% | 134,206 | +0.2% | 0.01% | -12.5% |
| Q2 2022 | $509,000 | -27.8% | 133,943 | +2.4% | 0.01% | -20.0% |
| Q1 2022 | $705,000 | -60.8% | 130,842 | -1.7% | 0.01% | -54.5% |
| Q4 2021 | $1,798,000 | -26.4% | 133,060 | -2.1% | 0.02% | -26.7% |
| Q3 2021 | $2,442,000 | +4.8% | 135,964 | +0.1% | 0.03% | +11.1% |
| Q2 2021 | $2,331,000 | -14.4% | 135,861 | -0.2% | 0.03% | -20.6% |
| Q1 2021 | $2,722,000 | +11.1% | 136,107 | -5.5% | 0.03% | +9.7% |
| Q4 2020 | $2,449,000 | -11.7% | 144,049 | -13.8% | 0.03% | -16.2% |
| Q3 2020 | $2,773,000 | -14.9% | 167,132 | +18.8% | 0.04% | -28.8% |
| Q2 2020 | $3,257,000 | +21.8% | 140,627 | -6.2% | 0.05% | +6.1% |
| Q1 2020 | $2,675,000 | +3.0% | 149,851 | +24.5% | 0.05% | +22.5% |
| Q4 2019 | $2,597,000 | +340.9% | 120,332 | +271.8% | 0.04% | +344.4% |
| Q3 2019 | $589,000 | -50.8% | 32,361 | -3.7% | 0.01% | -52.6% |
| Q2 2019 | $1,196,000 | +5.1% | 33,615 | -0.8% | 0.02% | +5.6% |
| Q1 2019 | $1,138,000 | -0.5% | 33,870 | -2.7% | 0.02% | -10.0% |
| Q4 2018 | $1,144,000 | -51.5% | 34,814 | -10.1% | 0.02% | -39.4% |
| Q3 2018 | $2,360,000 | +22.9% | 38,717 | -1.5% | 0.03% | +26.9% |
| Q2 2018 | $1,920,000 | -56.5% | 39,317 | -5.4% | 0.03% | -55.9% |
| Q1 2018 | $4,418,000 | -30.5% | 41,580 | -60.9% | 0.06% | -26.2% |
| Q4 2017 | $6,357,000 | +132.1% | 106,443 | -6.7% | 0.08% | +128.6% |
| Q3 2017 | $2,739,000 | +23.7% | 114,126 | +0.8% | 0.04% | +20.7% |
| Q2 2017 | $2,215,000 | -15.3% | 113,276 | +1.7% | 0.03% | -14.7% |
| Q1 2017 | $2,614,000 | +91.1% | 111,374 | -0.1% | 0.03% | +88.9% |
| Q4 2016 | $1,368,000 | -23.5% | 111,470 | +7.0% | 0.02% | -25.0% |
| Q3 2016 | $1,789,000 | +20.6% | 104,161 | -0.0% | 0.02% | +20.0% |
| Q2 2016 | $1,483,000 | -0.3% | 104,189 | -3.7% | 0.02% | +5.3% |
| Q1 2016 | $1,487,000 | -20.1% | 108,165 | -2.0% | 0.02% | -17.4% |
| Q4 2015 | $1,860,000 | +55.1% | 110,399 | +0.9% | 0.02% | +53.3% |
| Q3 2015 | $1,199,000 | -14.1% | 109,427 | -1.9% | 0.02% | -6.2% |
| Q2 2015 | $1,396,000 | – | 111,602 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rhenman & Partners Asset Management AB | 508,000 | $6,132,000 | 1.80% |
| Bodri Capital Management, LLC | 250,000 | $3,018,000 | 1.46% |
| Granahan Investment Management | 3,442,980 | $41,557,000 | 1.28% |
| TIRSCHWELL & LOEWY INC | 603,441 | $7,284,000 | 1.22% |
| NEA Management Company, LLC | 1,825,600 | $22,035,000 | 1.12% |
| Cormorant Asset Management, LP | 450,000 | $5,432,000 | 1.12% |
| HARVEY CAPITAL MANAGEMENT INC | 221,750 | $2,676,000 | 1.05% |
| Cheyne Capital Management (UK) LLP | 229,577 | $2,772,000 | 0.99% |
| Artal Group S.A. | 1,650,000 | $19,916,000 | 0.73% |
| FIC CAPITAL INC | 147,293 | $1,778,000 | 0.71% |